NCT05622903 is a NA clinical trial of Cash Benefit in Health Care Utilization, sponsored by Harvard Medical School (HMS and HSDM).

Who is sponsoring NCT05622903?

NCT05622903 is sponsored by Harvard Medical School (HMS and HSDM).

What drugs are being tested in NCT05622903?

Interventions in NCT05622903: Cash Benefit, No Cash Benefit.

What condition does NCT05622903 study?

NCT05622903 studies Health Care Utilization.

Is NCT05622903 still recruiting?

NCT05622903 is currently completed. Last updated 12 July 2024.

Last reviewed 2024-07-12 · How we verify

NCT05622903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Cash Benefits on Health Care Utilization

Completed NA Last updated 12 July 2024

What this trial tests

NA trial testing Cash Benefit in Health Care Utilization in 3,615 participants. Completed in 1 February 2024.

Timeline

27 July 2020

Primary endpoint
31 December 2021

1 February 2024

Quick facts

Lead sponsor	Harvard Medical School (HMS and HSDM)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	3,615
Start date	27 July 2020
Primary completion	31 December 2021
Estimated completion	1 February 2024
Sites	1 location across United States

Drugs / interventions tested

Cash Benefit
No Cash Benefit

Conditions studied

Health Care Utilization — all drugs for Health Care Utilization →

Sponsor

Harvard Medical School (HMS and HSDM)

Who can join

Eligibility, any sex, with Health Care Utilization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using data from the Chelsea Eats program, we propose to study a randomized controlled trial in which the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months during the first two years of the COVID-19 pandemic. We will analyze the impact of the cash benefit on health care utilization and health.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
Agarwal SD, Cook BL, Liebman JB. · · 2024 · cited 22× · PMID 39037892 · DOI 10.1001/jama.2024.13004

Verify or expand the search:

Other trials of Cash Benefit

Trials testing the same drug.

NCT05782660 — Cash Benefits and Reproductive/Perinatal Health · NA · active not recruiting

Other recruiting trials for Health Care Utilization

Currently open trials in the same condition.

NCT06999928 — Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV · NA · recruiting
NCT06604559 — The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using · NA · recruiting
NCT05454969 — One-4-ALL Initiative · NA · recruiting
NCT05989282 — Structural Conditions and Health After Release From Prison · recruiting
NCT06186128 — Universal Basic Income and Structural Racism in the US South: HIV Care · NA · recruiting

Other Harvard Medical School (HMS and HSDM) trials

Trials by the same sponsor.

NCT07440303 — Star Matrix vs Autogenous Graft for Gingival Augmentation: Split-Mouth RCT · NA · recruiting
NCT07203885 — AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Onl · NA · completed
NCT07090863 — Additively Versus Subtractively Manufactured Implant Supported Fixed Dental Prostheses · NA · not yet recruiting
NCT07307157 — Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist- · enrolling by invitation
NCT06651502 — Efficacy of a Dental Implant System for Immediate Restoration · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05622903 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Harvard Medical School (HMS and HSDM)
Last refreshed: 12 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05622903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing